Cargando…
Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse
Gluten proteins are known as immunological triggers for inflammation resulting in mucosal lesions in patients with coeliac disease (CD). Adherence to a strict gluten-free diet (GFD) is currently known as the only effective treatment for CD. In this study, we performed a systematic review and dose-re...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057462/ https://www.ncbi.nlm.nih.gov/pubmed/36986121 http://dx.doi.org/10.3390/nu15061390 |
_version_ | 1785016373360984064 |
---|---|
author | Rostami-Nejad, Mohammad Asri, Nastaran Olfatifar, Meysam Khorsand, Babak Houri, Hamidreza Rostami, Kamran |
author_facet | Rostami-Nejad, Mohammad Asri, Nastaran Olfatifar, Meysam Khorsand, Babak Houri, Hamidreza Rostami, Kamran |
author_sort | Rostami-Nejad, Mohammad |
collection | PubMed |
description | Gluten proteins are known as immunological triggers for inflammation resulting in mucosal lesions in patients with coeliac disease (CD). Adherence to a strict gluten-free diet (GFD) is currently known as the only effective treatment for CD. In this study, we performed a systematic review and dose-response meta-analysis on data from previous studies to investigate the association between different gluten doses administered and the risk of CD relapse. Electronic databases were systematically searched to retrieve studies that investigated the response of CD patients to different amounts of gluten intake and evaluated the clinical, serologic, and/or histologic evidence to recognize disease relapse. Study-specific relative risks (RRs) were combined using a random effects model. A total of 440 identified published papers were screened, of which 7 records were selected following full-text reviewing and eligibility assessment for dose-response meta-analysis. According to our analysis, the risk of CD relapse is estimated to be 0.2% (RR: 1.002; 95% CI: 1.001 to 1.004) following the consumption of 6 mg gluten/day, which was increased to 7% (RR: 1.07; 95% CI: 1.03 to 1.10), 50% (RR: 1.50; 95% CI: 1.23 to 1.82), 80% (RR: 1.80; 95% CI: 1.36 to 2.38), and 100% (RR: 2.00; 95% CI: 1.43 to 2.78) by the daily intake of 150, 881, 1276, and 1505 mg gluten, respectively. Although good adherence to a GFD can adequately control CD-related symptoms, disease relapse might happen even with a very low dose of gluten, and the duration of exposure to gluten is also an important matter. The current literature has substantial limitations, such as relying on the data from just a few countries that were different in terms of the amount of gluten administered, the duration of the challenge, etc. Therefore, more randomized clinical trials using a standardized gluten challenge protocol are needed to confirm the findings of the present study. |
format | Online Article Text |
id | pubmed-10057462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100574622023-03-30 Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse Rostami-Nejad, Mohammad Asri, Nastaran Olfatifar, Meysam Khorsand, Babak Houri, Hamidreza Rostami, Kamran Nutrients Systematic Review Gluten proteins are known as immunological triggers for inflammation resulting in mucosal lesions in patients with coeliac disease (CD). Adherence to a strict gluten-free diet (GFD) is currently known as the only effective treatment for CD. In this study, we performed a systematic review and dose-response meta-analysis on data from previous studies to investigate the association between different gluten doses administered and the risk of CD relapse. Electronic databases were systematically searched to retrieve studies that investigated the response of CD patients to different amounts of gluten intake and evaluated the clinical, serologic, and/or histologic evidence to recognize disease relapse. Study-specific relative risks (RRs) were combined using a random effects model. A total of 440 identified published papers were screened, of which 7 records were selected following full-text reviewing and eligibility assessment for dose-response meta-analysis. According to our analysis, the risk of CD relapse is estimated to be 0.2% (RR: 1.002; 95% CI: 1.001 to 1.004) following the consumption of 6 mg gluten/day, which was increased to 7% (RR: 1.07; 95% CI: 1.03 to 1.10), 50% (RR: 1.50; 95% CI: 1.23 to 1.82), 80% (RR: 1.80; 95% CI: 1.36 to 2.38), and 100% (RR: 2.00; 95% CI: 1.43 to 2.78) by the daily intake of 150, 881, 1276, and 1505 mg gluten, respectively. Although good adherence to a GFD can adequately control CD-related symptoms, disease relapse might happen even with a very low dose of gluten, and the duration of exposure to gluten is also an important matter. The current literature has substantial limitations, such as relying on the data from just a few countries that were different in terms of the amount of gluten administered, the duration of the challenge, etc. Therefore, more randomized clinical trials using a standardized gluten challenge protocol are needed to confirm the findings of the present study. MDPI 2023-03-14 /pmc/articles/PMC10057462/ /pubmed/36986121 http://dx.doi.org/10.3390/nu15061390 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Rostami-Nejad, Mohammad Asri, Nastaran Olfatifar, Meysam Khorsand, Babak Houri, Hamidreza Rostami, Kamran Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse |
title | Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse |
title_full | Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse |
title_fullStr | Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse |
title_full_unstemmed | Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse |
title_short | Systematic Review and Dose-Response Meta-Analysis on the Relationship between Different Gluten Doses and Risk of Coeliac Disease Relapse |
title_sort | systematic review and dose-response meta-analysis on the relationship between different gluten doses and risk of coeliac disease relapse |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057462/ https://www.ncbi.nlm.nih.gov/pubmed/36986121 http://dx.doi.org/10.3390/nu15061390 |
work_keys_str_mv | AT rostaminejadmohammad systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse AT asrinastaran systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse AT olfatifarmeysam systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse AT khorsandbabak systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse AT hourihamidreza systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse AT rostamikamran systematicreviewanddoseresponsemetaanalysisontherelationshipbetweendifferentglutendosesandriskofcoeliacdiseaserelapse |